You are here: Industry Insights > Pediatric

News List

FDA Approves Octapharma’s cutaquig® 16.5% for Pediatric PI Patients, Providing Flexible Treatment Options AmericanPharmaceuticalReview
December 10, 2021
Octapharma USA announced the FDA has approved cutaquig® [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved...
Peds Mortality Down for Presentation at ED With Higher Readiness drugs
August 26, 2019
Presentation to hospitals with an emergency department with high levels of readiness to care for pediatric emergencies is associated with reduced mortality...
Pediatric Cannabis Exposure Up After Medical Legalization drugs
August 19, 2019
Following medical marijuana legalization (MML) in Massachusetts in 2012, there was an increase in pediatric cannabis exposure, according to a study published online in JAMA Network Open.
Evidence Supports Meds Used for Pain Relief in Pediatric Migraine drugs
August 15, 2019
Evidence-based therapies are available for the acute symptomatic treatment of migraine in children and adolescents, but evidence is lacking for the impact of many treatments for migraine prevention...
No Evidence for Benefits of Opioids After Pediatric Tonsillectomy drugs
August 12, 2019
For children undergoing tonsillectomy, having perioperative opioid fills is not associated with return visits for pain or dehydration, according to a study published online in JAMA Otolaryngology-Head & Neck Surgery.
Overweight, Obesity May Up Early Mortality Risk in Pediatric ALL drugs
August 06, 2019
For Mexican children with acute lymphoblastic leukemia (ALL), overweight and obesity are predictors of early mortality...
Most Pediatric In-Flight Medical Events Handled by Crew drugs
July 26, 2019
Most pediatric in-flight medical events (IFMEs) are handled by crewmembers, according to a study published online July 25 in the Annals of Emergency Medicine.
Penta, Cromsource Partner to Improve Pediatric Drug Development contractpharma
July 26, 2019
Aims to expedite availability of new products to address unmet medical needs of children around the world.
Obesity Linked to Increased Risk for Pediatric Multiple Sclerosis drugs
July 16, 2019
Obesity seems to be associated with increased odds of pediatric multiple sclerosis (MS), according to a study published online in JAMA Neurology.
FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity drugs
June 24, 2019
FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity.

Previous page 1 2 Next page